TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Need for Massive Blood Transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: postoperative opioid usage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Life Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Motion Sickness Assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Barrier function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve (AUC[0-∞]) of Dabigatran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve (AUC[0-∞]) of Rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment rate overall and by study site
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence to MET-2/placebo for the treatment duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing of Grade 2 or 3 radiodermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from baseline in body temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment-emergent adverse event and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Changes of executive function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in cardiac output reserve (Qc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Temporal Summation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade of oral mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic responses
Endpoint domain: Adverse events/effects
Primary endpoint: Health Knowledge Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Healthy Food Choice Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Team fidelity to the quality improvement implementation process
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Level of readiness for change (R4C) among study participants
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participant Fidelity to the LeaderShift Program
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Rate of radial artery occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Total time to hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pregnancy outcomes in growth-restricted pregnancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Endotracheal tube occlusion requiring emergency tube change
Endpoint domain: Adverse events/effects
Primary endpoint: Wait times
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: accuracy of the ROSE-AI system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity of the ROSE-AI system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity of the ROSE-AI system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined Rate of Complete Response (CR) and Very Good Partial Response (VGPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Calories Purchased
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Heat strain marker variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrical Impedance Tomography of Pulmonary (EIT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adult ADHD Self-Rating Scale (ASRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adult ADHD Quality of Life Measure (AAQol)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Concentration of DOXO and metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infection inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Perfusion units at various regions of interest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temperature at various regions of interest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation with the chance of developing ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of the resting metabolic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of the daily energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of patients who Return to Sport
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: PROMIS scores for Physical Function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ACL-Return to Sport after Injury (ACL-RSI) scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Women Consenting to Have Mastectomy Flap Temperatures Measured During Surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Women Having All Relevant Flap Temperatures Measured
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Hip abductors strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Knowledge of abuse
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Acceptability of the study medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Robotic-assisted mini-Percutaneous Nephrolithotomy (PCNL) Kidney Stone Removal Procedure Completed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of primary postpartum haemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Moderate to vigorous physical activity (MVPA)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in PROMIS Pain Quality - Neuropathic Pain (PQ-Neuro) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of anti-AAV8 antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: time of hematopoietic recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: AUCt of Irbesartan High and Amlodipine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cmax of Irbesartan High and Amlodipine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient discomfort related to BTX-A injection
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Chewing difficulty
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean Change from Baseline to Week 7 in Anxiety Sensitivity-3 (ASI-3) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean PTSD Checklist for Diagnostic and Statistical Manual (DSM)-5 (PCL-5) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Participant above Clinically-Significant Cut-off for Drug Abuse Screening Test (DAST)
Endpoint domain: Adverse events/effects
Primary endpoint: Knowledge about authentic leadership
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Authentic leadership behavior
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Nursing care self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Trust in workplace
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Injuries per 1000 training hours
Endpoint domain: Adverse events/effects
Primary endpoint: Injuries per 1000 game hours
Endpoint domain: Adverse events/effects
Primary endpoint: All-cause mortality within 7 days after randomization
Endpoint domain: Mortality/survival
Primary endpoint: Photoreceptor (PR) density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal pigment epithelial (RPE) cell density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RPE cell organelle motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PR cell function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Mu-positive NK cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from Baseline in Oropharyngeal Fat at 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Baseline Apnea Hypopnea Index at 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive Predictive Value/Precision (PPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper quarter Y-balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biodex limits of stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in auditory vocal hallucinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mental imagery characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of language function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in baseline hemoglobin levels at 9 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes of glomerular filtration rate at baseline at 9 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in the guiding symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of 89Zr-KN035
Endpoint domain: Adverse events/effects
Primary endpoint: Change in psychological inflexibility
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of allergy development in the delivered infants
Endpoint domain: Adverse events/effects
Primary endpoint: Central arterial stiffness measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: IHC analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Gastroparesis Cardinal Symptom Index total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Diaphragm Thickening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Perception of recurrence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reactance-volume loop area (AXV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean inspiratory minus expiratory respiratory system reactance (mean ∆Xrs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Face Legs Activity Cry Consolability (FLACC) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total score of the Montgomery Åsberg Depression Rating Scale (MADRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: post-surgery pathology concordance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distribution of Modified Rankin scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 2-week change in the Patient Health Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 2-week change in the Generalized Anxiety Disorder 7 scale (GAD7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 8-week change in the Patient Health Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 8-week change in the Generalized Anxiety Disorder 7 scale (GAD7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in body's postural symmetry index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-point improvement in the global NRS
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The Star Excursion Balance Test (SEBT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1 RM Leg Press test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent change in submaximal Shape Cardiopulmonary exercise testing (Shape CPET) metrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 6 minute walk time distance (6MWTd)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Bioavailability of Methylprednisolone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination of acute headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean titer (GMT) of SARS-CoV-2-specific neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rate (SCR) of SARS-CoV-2-specific neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of patients with PLT ≥ 50 × 10^9/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Glucose-to-potassium ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Subjective Drug Effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Targeted Pain Responder Rate
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Soft Cost Savings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Process Improvement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Quality Improvement
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Daily Eating Opportunity Window
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of micturition episodes per 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cardiac epicardial fat volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of solicited local reactogenicity AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of solicited systemic reactogenicity AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of any serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of any medically attended adverse events (MAAES)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in safety laboratory values from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in UCLA Loneliness Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean Change in Medical Outcomes Study (MOS) Social Support Survey - Total Score
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Mean change in Early Treatment Diabetic Retinopathy Study (ETDRS) Best Corrected Visual Acuity (BCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in uncorrected Visual Acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in Standardized Patient Evaluation of Eye Dryness (SPEED) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to resolution of shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vasopressor Responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification and Quantification of Sézary Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Diagnostic accuracy of fundus OCTA-derived parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global Assessment Rating Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pathological CPET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: full stomach rate after finishing MgSO4 solution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: FVC<80%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FVC>80%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: step test: heart rate recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neutralization GMTR SARS-CoV-2 pseudovirus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Speech audiometric performances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient reported outcome measures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Resting State Gamma Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Auditory Steady State Response Gamma Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration max (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in tissue visualization in CBCT images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of Sickleave
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Return to Work Self-efficacy 11
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Major Depressive Disorder (MDD) symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-traumatic Stress Disorder (PTSD) symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first knee or hip replacement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: acute urinary toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: acute bowel toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Knowledge of drug effects
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: plasma myokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain during Extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Disease Activity Score (DAS) for 28-joint count using C-reactive protein (DAS28-CRP) at Week 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects who achieve remission (DAS28-CRP <2.6) at Weeks 4, 8, 12, and 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects who achieve low disease activity (DAS28-CRP <3.2) at Weeks 4, 8, 12, and 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Zarit Caregiving Burden Scale
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Adult Caregiver Quality of Life Survey
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean Score Perceived Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in the difference between the proportion of hits minus false alarms for a given level of the N-back task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the proportion of correctly reported sequences in the Corsi Complex task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the proportion of correctly reported number and letter sets in the Letter-Number task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Michigan Hand Outcome Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinical success within 180 days
Endpoint domain: Mortality/survival
Primary endpoint: platelet reconstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Respiratory Muscle Strength (MIP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Respiratory Muscle Strength (MEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: SOFA (Sequential Organ Failure Assessment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Glasgow Coma Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Dental Implant Survival
Endpoint domain: Mortality/survival
Primary endpoint: Change of tympanic membrane perforation size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes